EBACU (European Biotech Acquisition) Earnings Yield (Joel Greenblatt) % : -1.70% (As of Dec. 2022)

European Biotech Acquisition Earnings Yield (Joel Greenblatt) % Chart

Competitive Comparison of European Biotech Acquisition's Earnings Yield (Joel Greenblatt) %

For the Shell Companies subindustry, European Biotech Acquisition's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Biotech Acquisition's Earnings Yield (Joel Greenblatt) % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, European Biotech Acquisition's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where European Biotech Acquisition's Earnings Yield (Joel Greenblatt) % falls into.

European Biotech Acquisition Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

European Biotech Acquisitions Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2022 is calculated as

European Biotech Acquisition's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.82 Mil.

European Biotech Acquisition  (NAS:EBACU) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

European Biotech Acquisition Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of European Biotech Acquisition's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

European Biotech Acquisition Business Description